# Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

> **NCT00238953** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 30 (actual)

## Conditions studied

- Renal Transplantation

## Interventions

- **DRUG:** Enteric-Coated Mycophenolate Sodium (EC-MPS)

## Key facts

- **NCT ID:** NCT00238953
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-02
- **Primary completion:** 2006-06
- **Final completion:** 2006-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00238953

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00238953, "Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00238953. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*